Skip to main content
. 2010 Jul 1;95(7 Suppl 1):s1–s66. doi: 10.1210/jc.2009-2509

Fig. 2.

Fig. 2.

Increase in BMD in postmenopausal women treated with alendronate or estrogen, alone or in combination. PLO, Placebo; ALN, alendronate; CE, conjugated estrogen. [Reproduced with permission from H. G. Bone et al. J Clin Endocrinol Metab 85:720–726, 2000 (75). © The Endocrine Society.]